NR1H3 and metabolic dysfunction-associated steatotic liver disease: Finally, Nakamuta et al., who included a cohort of obese patients, observed that the expression of LXRα and ACC1 was upregulated in NAFLD and it was more noticeable in non-obese than in obese patients [19].